Orbital Therapeutics
Aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€982m—1.5b (Dealroom.co estimates Apr 2023.)
San Francisco California (HQ)
Authorizing premium user...